1. ICH Q3A(R2) 2006 Impurities in new drug substances
2. ICH Q3B(R2) 2006 Impurities in new drug products
3. ICH Q3C(5) 2011 Impurities: Guidelines for residual solvents
4. ICH Q3D 2014 Guideline for elemental impurities
5. ICH M7 2014 Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk